Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Good week for LSE and Chi-X but LSE domination of FTSE 100 looks unlikely

It was a crazy week for markets last week but it looks like the beneficiaries in terms of venues were Chi-X and the LSE at the expense of Turquoise. I guess that’s a reflection that Chi-X is now seen as an established venue (alongside the LSE) whilst Turquoise has still to prove itself. It may also reflect the fact that that Turquoise’s members have had other things on their mind (like survival). It’s also interesting, however, if you take a longer term view as the future for the LSE doesn’t look so rosy. The FFI for the FTSE 100 has risen from 1.2 in April to just over 1.65 in October. The implication of this is that within another 6 months the FTSE FFI will have breached 2 at which point the LSE monopoly on these stocks is effectively over. With Bats and Nasdaq OM only just getting warmed up this will put even more pressure on the LSE to resurrect Baikal and deliver on its other initiatives aimed at maintaining its trading volume.

Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.